Resultado Líquido Alterar Data
AbbVie USD 4.22B 605M 2026-09
Alterity Therapeutics Limited AUD -6.3M 525.41K 2025-12
Cipla INR 8.78B 884.9M 2026-09
Clal Biotechnology ILS -6.17M 15.56M 2022-12
Compugen USD -7.01M 663K 2026-06
CSL USD 401M 96.5M 2025-12
Grifols EUR 114.37M 34.03M 2025-12
Novo Nordisk DKK 3.26B 45.29B 2026-06
Pfizer USD 3.24B 3.49B 2026-09
TherapeuticsMD USD -1.09M 356K 2024-06